1. Home
  2. ARCT vs ECX Comparison

ARCT vs ECX Comparison

Compare ARCT & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • ECX
  • Stock Information
  • Founded
  • ARCT 2013
  • ECX 2017
  • Country
  • ARCT United States
  • ECX China
  • Employees
  • ARCT N/A
  • ECX N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • ECX EDP Services
  • Sector
  • ARCT Health Care
  • ECX Technology
  • Exchange
  • ARCT Nasdaq
  • ECX Nasdaq
  • Market Cap
  • ARCT 298.3M
  • ECX 589.5M
  • IPO Year
  • ARCT N/A
  • ECX N/A
  • Fundamental
  • Price
  • ARCT $13.36
  • ECX $2.37
  • Analyst Decision
  • ARCT Strong Buy
  • ECX Strong Buy
  • Analyst Count
  • ARCT 8
  • ECX 1
  • Target Price
  • ARCT $52.83
  • ECX $3.20
  • AVG Volume (30 Days)
  • ARCT 484.0K
  • ECX 3.6M
  • Earning Date
  • ARCT 08-04-2025
  • ECX 08-07-2025
  • Dividend Yield
  • ARCT N/A
  • ECX N/A
  • EPS Growth
  • ARCT N/A
  • ECX N/A
  • EPS
  • ARCT N/A
  • ECX N/A
  • Revenue
  • ARCT $143,680,000.00
  • ECX $805,604,079.00
  • Revenue This Year
  • ARCT N/A
  • ECX $26.72
  • Revenue Next Year
  • ARCT $34.79
  • ECX $30.34
  • P/E Ratio
  • ARCT N/A
  • ECX N/A
  • Revenue Growth
  • ARCT 15.38
  • ECX 19.98
  • 52 Week Low
  • ARCT $8.04
  • ECX $0.76
  • 52 Week High
  • ARCT $25.88
  • ECX $3.25
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 54.34
  • ECX 65.11
  • Support Level
  • ARCT $13.10
  • ECX $2.01
  • Resistance Level
  • ARCT $15.20
  • ECX $2.29
  • Average True Range (ATR)
  • ARCT 1.02
  • ECX 0.17
  • MACD
  • ARCT 0.07
  • ECX 0.01
  • Stochastic Oscillator
  • ARCT 55.21
  • ECX 76.36

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: